Cure My Disease

Don't miss your cure!

 Log in / Sign up

Music and lidocaine timing: a simple recipe for a gentler cystoscopy?

NCT ID NCT07795255

Symptom relief Sponsor: Florian Schroeck Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 02, 2026 · Updated 2 times

Summary

This trial tests whether listening to music or letting numbing medication sit longer can reduce pain during cystoscopy, a procedure that examines the bladder. About 1,740 people undergoing cystoscopy for bladder cancer diagnosis or surveillance will be randomly assigned to different combinations of music and lidocaine dwell times. Researchers will measure pain and anxiety levels to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Listening to music via headphones and lidocaine numbing medication with different dwell times
What this could lead to
If it works, this could give doctors simple, low-cost ways to make cystoscopy more comfortable for patients, reducing pain and anxiety during the procedure.
What could go wrong
The trial is testing two interventions at once, so it may be hard to tell which one helps. Also, results may vary depending on individual pain tolerance and music preference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 1,740 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Sep 2031

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Undergoing office-based cystoscopy for bladder cancer diagnosis, surveillance, or evaluation of anatomic abnormalities. Exclusion Criteria: * Allergy to or intolerance of lidocaine. * Intolerance of all offered music genre playlists (Jazz, Classical, New Age), such that no acceptable music option exists. * Known pregnancy or lactation (routine pregnancy testing is not required)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder (urothelial, transitional cell) cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hematuria neoplasm urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder (urothelial, transitional cell) cancer Hematuria

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Novant Health New Hanover Regional Medical Center

    Wilmington, North Carolina, 28401, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35233, United States

  • University of North Carolina

    Chapel Hill, North Carolina, 27599, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, 75390, United States

  • White River Junction Veterans Healthcare System

    White River Junction, Vermont, 05009, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.